Month: April 2025

Bollène (France), April 30, 2025 – 06 :00pm (CET)Press Release 2024 Annual Results Egide Group (Euronext Growth Paris™- ISIN : FR0000072373 – Ticker : ALGID), worldwide provider of hermetic packages and connectors and heat dissipation solutions for sensitive electronic components, announces today its 2024 results, now presented according to French accounting standards (French GAAP) instead of international IFRS standards. The statutory auditors’ reports are expected at a later date. The figures presented below are therefore unaudited but have been reviewed and approved by the Board of Directors which met on April 29, 2025. The results for fiscal year 2024 reflect a contraction in revenue (-18%) to €30.04M (slightly adjusted from the preliminary figure of €31.07M announced on January 20, 2025), and a significant improvement...

Ekati Diamond Mine Misery UndergroundOngoing operations at Ekati’s Misery Underground mine.CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) — Burgundy Diamond Mines Limited (ASX:BDM) (Burgundy or the Company) provided the filing of its financial and operating results for the first quarter (Q1-2025) ended March 31, 2025, to the Australian Stock Exchange on April 30, 2025. During the quarter, Ekati’s operational team fully relocated surface mining equipment to Point Lake and transferred production personnel to the Misery camp. “This co-location of Point Lake and Misery unlocks improved operational efficiencies, increases effective shift time, and enables a step change downward in mining costs,” said Kim Truter, CEO of Burgundy Diamond Mines. The transition to Point Lake saw some ore supply disruption due to wet and...

Landsbankinn’s after-tax profit during the first three months of 2025 was ISK 7.9 billion, compared with ISK 7.2 billion for the same period of 2024. Return on equity (ROE) in the period was 10.0%, compared with 9.3% for the same period the previous year. Net interest margin as a ratio of average total asset position was 2.7%, compared with 2.9% for the same period of 2024. The net interest margin of domestic households was 2.1%, unchanged from 2024. Net interest income amounted to ISK 14.8 billion and net fee and commission income was ISK 3.0 billion. Both items are up between years. The cost-income ratio was 38.7%, compared with 33.6% for the same period of 2024. The total capital ratio was 23.6% at the end of the period. The Financial Supervisory Authority (FSA) of the Central  Bank of Iceland sets the total capital requirement at...

HighlightsThe Hearing division delivered -1% organic revenue growth driven by a strong initial uptake of ReSound Vivia, but off-set by a challenged U.S. market as well as some slowdown of existing products in anticipation of ReSound Vivia. The strong uptake of ReSound Vivia has continued into April, lending support for expected market share gains. As a consequence of the launch initiatives and the challenged U.S. market, the divisional profit margin ended at 28.4%. The Enterprise division was challenged in the quarter with -9% organic revenue growth due to a demanding comparison base from several large deals in Q1 2024 and the current global macroeconomic uncertainty. The sell-out growth was stronger at -5%. As a result of strong pricing discipline and cost focus, the divisional profit margin ended at 32.9%. The Gaming division experienced...

              Champfromier, Wednesday, April 30, 2025 TURNOVER FOR THE FIRST QUARTER OF 2025Turnover down -3.0% Net cash position of €149.6MAKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and structural parts for electric vehicles, has recorded, over the first quarter of 2025, a consolidated turnover of €255.6M, down -3.0% compared to the results published for the first quarter of 2024. Consolidated turnover for the first quarter of 2025 (from January 1 to March 31)in €m — unaudited 2025 2024 Variation PCC variation (*)1st quarter 255.6 263.5 -3.0% -4.0%(*) At constant scope and exchange rates DECLINE IN CONSOLIDATED TURNOVER In the first quarter of 2025, global automotive production fell in most of the key automotive...

Communiqué de presse Mise à disposition du rapport financier annuel 2024 Dijon, France le 30 avril 2025 (17h45 CET) — CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique spécialisée en phase avancée de développement et d’enregistrement de ZEPIZURE®, sa solution d’urgence pour la gestion des crises d’épilepsie, annonce avoir mis à la disposition du public et déposé auprès de l’Autorité des Marchés Financiers son rapport financier annuel 2024. Le rapport financier annuel 2024 peut être consulté sur le site internet de la société. À propos de CROSSJECT CROSSJECT SA (Euronext : ALCJ ; www.crossject.com) est une société pharmaceutique spécialisée émergente. Elle est en phase de développement réglementaire avancé pour ZEPIZURE®, un traitement d’urgence dans la prise en charge des crises épileptiques pour lequel...

Enclosed is the trading statement of Skel fjárfestingafélag hf. for the first quarter of 2025.  For further information, or to request a meeting, please contact fjarfestar@skel.is  AttachmentTrading statement Q1 2025